Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 686, 74-79
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (WA1441/18-2)
This publication has 24 references indexed in Scilit:
- G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase AHypertension, 2016
- Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 2011
- Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral EndopeptidasePLOS ONE, 2009
- Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-β peptidesEuropean Journal of Pharmacology, 2008
- Aβ Oligomers – a decade of discoveryJournal of Neurochemistry, 2007
- Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studiesPeptides, 2004
- Possible increased risk for Alzheimer's disease associated with neprilysin geneJournal of Neural Transmission, 2003
- Metalloenzyme-like Activity of Alzheimer's Disease β-AmyloidJournal of Biological Chemistry, 2002
- Aβ Deposition Does Not Cause the Aggregation of Endogenous Tau in Transgenic MiceAlzheimer Disease & Associated Disorders, 2002
- Study of the Conformational Transition of Aβ(1−42) Using d-Amino Acid Replacement AnaloguesBiochemistry, 2001